A Study of AK3280 in Chinese Healthy Volunteers

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This study is a randomized, double-blind, placebo-controlled, single-center, phase I study to evaluate the safety, tolerability, and pharmacokinetics of AK3280 in healthy Chinese subjects.
Epistemonikos ID: 730a2b2852a10808937f2fd51aabb595c4bcfcbb
First added on: May 09, 2024